• WEBINAR
    Wednesday, July 12, 2017 at 12:00 EST
    Role of Elastrography in Chronic Liver Disease: The AGA Guidelines

    REGISTER HERE
  • Echosens
    North America
    is your innovation partner
    for non-invasive liver
    disease diagnostics

    Learn More
  • The industry standard
    for the non-invasive
    assessment of
    liver diseases.

    Learn More
  • Dual Function
    Liver Diagnostics
    VCTE and CAP
    State-of-the-art of non-invasive
    liver diagnostics

    Learn More
  • Engineered with
    Smart Tools to support
    consistency, irrespective of
    operator and across most
    patient morphologies.

    Learn More

Innovation in Liver Disease Management
Using patented Vibration Controlled Transient Elastography (VCTE), the FibroScan® 502 Touch is the first noninvasive device indicated for use as an aid in the clinical management of patients with liver disease.

Learn More →

Enhancing access through mobility
The FibroScan® 530 Compact offers the same dual function capabilities and examination experience as the FibroScan® 502 Touch.

Learn More →

In North America, there are more than 350 FibroScan® systems. We’re growing fast!

Check out our map →

Echosens is now your direct partner in the United States.

Contact Us

Video Library

 

Using patented VCTE and CAP, FibroScan® is the first totally non-invasive device indicated for use as an aid in the clinical management of patients with liver disease. The examination with FibroScan® is rapid and easily repeatable over time. This unique, accurate and efficient device brings extra confidence to patient management.